Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$174,474
-$5,666,360 QoQ
Shares Held
12,167
-98.1% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#107
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Derivatives in ZVRA

reported options exposure · as of Jun 30, 2026
CallValue
$5,446,332
CallShares
379,800
PutValue
$493,296
PutShares
34,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. ZVRA ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in ZVRA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $493,296 34,400
2026-06-30 $174,474 12,167
2026-06-30 $5,446,332 379,800
2026-03-31 $5,840,834 626,699
2026-03-31 $2,268,488 243,400
2026-03-31 $391,440 42,000
2025-12-31 $7,551,970 842,854
2025-12-31 $1,408,512 157,200
2025-12-31 $501,760 56,000
2025-09-30 $1,823,979 191,796
2025-09-30 $970,971 102,100
2025-09-30 $1,137,396 119,600
2025-06-30 $607,009 68,900
2025-06-30 $1,006,691 114,267
2025-03-31 $29,211 3,900
2025-03-31 $1,863,751 248,832
2025-03-31 $695,072 92,800
2024-12-31 $20,758 2,489
2024-12-31 $701,394 84,100
2024-12-31 $200,994 24,100
2024-09-30 $926,490 133,500
2024-09-30 $298,420 43,000
2024-09-30 $471,288 67,909
2024-06-30 $515,666 105,238
2024-06-30 $87,220 17,800
2024-06-30 $98,000 20,000
2024-03-31 $1,885 325
2024-03-31 $166,837 28,765
2024-03-31 $91,640 15,800
2023-12-31 $2,192,789 334,777
2023-12-31 $557,830 85,165
2023-12-31 $260,035 39,700
2023-09-30 $808,168 167,670
2023-09-30 $151,830 31,500
2023-09-30 $319,566 66,300
2023-06-30 $242,250 47,500
2023-06-30 $431,970 84,700
2023-06-30 $145,048 28,441
2023-03-31 $502,150 91,300
2023-03-31 $171,523 31,186
2023-03-31 $577,500 105,000
2022-12-31 $1,116,747 243,300
2022-12-31 $348,381 75,900
2022-12-31 $499,667 108,860
2022-09-30 $1,418,352 227,300
2022-09-30 $1,663,584 266,600
2022-06-30 $1,102,958 247,300
2022-06-30 $1,120,352 251,200
2022-03-31 $1,678,511 333,700
2022-03-31 $1,272,087 252,900